Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Pricing snapshots
Regulatory databases
Product category trackers
Regulatory reports
Market reports
Infographics
Market Snapshots
News analysis
Flavour & nicotine trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Maine - United States Flavour ban documents introduced…
  • Taiwan Fines coming into force for selling or using e-cigs…
  • United Kingdom ‘Smokefree 2030’ – government promises proposals soon…
  • United States Schumer tells FDA to take strong action against ‘kid-friendly’ Elf Bar…
  • Belgium E-cigarette notification lists updated…
  • United Kingdom Counterfeit e-cigs seized…
  • Italy Ministers plan new administrative procedures for e-cig sales network…
  • Egypt Customs clarifies e-cig tax rates…
  • Bahrain Health ministry oversight extended for nicotine product standards…
  • Bulgaria Finance ministry introduces draft law increasing e-cig taxes…
  • Europe EU member states want more flexible packaging law…
  • Netherlands Inspection finds many stores violate display ban…
View all
News analysis

FDA demands early PMTAs for flavoured e-cigs, sets limits on retail

Written by || 13th March 2019 || News analysis || FDA | Regulation and Legislation | North America United States

The US FDA has spelled out details of its planned crackdown on flavoured e-cigarettes, including retail restrictions and an earlier PMTA deadline for most flavoured products ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Cancer Institute head Sharpless to follow Gottlieb as acting FDA chief
Exit Gottlieb, the ‘friend of vaping’ who became its outspoken foe
‘Not on my watch’: Gottlieb escalates FDA war on youth vaping